IMV Extends Runway with $25M Raise

Dartmouth-based drug discovery company IMV Inc. has enough cash to finance its operations until mid-2021 now that it has closed a $25.1 million private placement of shares and warrants.
The company, whose shares are listed on the TSX in Toronto and the Nasdaq exchange in New York, earlier this month announced the placement co-led by existing investor Fonds de Solidarité FTQ of Montreal and